Insider · CIK 0001598640

Dumas Jacques

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001598640

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-01-17	TETRAPHASE PHARMACEUTICALS INCRestricted Stock UnitsA Award	Chief ScientificOfficer	AAward	+140K sh	—	—	140,000
2019-01-17	TETRAPHASE PHARMACEUTICALS INCRestricted Stock UnitA Award	Chief ScientificOfficer	AAward	+40K sh	—	—	40,000
2019-01-08	TETRAPHASE PHARMACEUTICALS INCS Sale	Chief ScientificOfficer	SSale	−7,497 sh	$1.60	−$12K	0
2018-04-02	TETRAPHASE PHARMACEUTICALS INCRestricted Stock UnitsA Award	Chief ScientificOfficer	AAward	+40K sh	—	—	40,000
2018-01-30	TETRAPHASE PHARMACEUTICALS INCM Exercise/Conversion	Chief ScientificOfficer	MExercise/Conversion	+8,750 sh	$3.69	+$32.3K	8,750
2018-01-30	TETRAPHASE PHARMACEUTICALS INCS Sale	Chief ScientificOfficer	SSale	−8,750 sh	$6.22	−$54.4K	0
2018-01-30	TETRAPHASE PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Chief ScientificOfficer	MExercise/Conversion	−8,750 sh	—	—	105,000
2018-01-17	TETRAPHASE PHARMACEUTICALS INCRestricted Stock UnitA Award	Chief ScientificOfficer	AAward	+40K sh	—	—	40,000
2018-01-17	TETRAPHASE PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award	Chief ScientificOfficer	AAward	+140K sh	—	—	140,000
2017-10-31	TETRAPHASE PHARMACEUTICALS INCM Exercise/Conversion	Chief ScientificOfficer	MExercise/Conversion	+8,750 sh	$3.69	+$32.3K	8,750
2017-10-31	TETRAPHASE PHARMACEUTICALS INCS Sale	Chief ScientificOfficer	SSale	−8,750 sh	$6.03	−$52.8K	0
2017-10-31	TETRAPHASE PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Chief ScientificOfficer	MExercise/Conversion	−8,750 sh	—	—	113,750
2017-08-22	TETRAPHASE PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Chief ScientificOfficer	MExercise/Conversion	−17.5K sh	—	—	122,500
2017-08-22	TETRAPHASE PHARMACEUTICALS INCM Exercise/Conversion	Chief ScientificOfficer	MExercise/Conversion	+17.5K sh	$3.69	+$64.6K	17,500
2017-08-22	TETRAPHASE PHARMACEUTICALS INCS Sale	Chief ScientificOfficer	SSale	−17.5K sh	$6.00	−$105K	0
2017-08-17	TETRAPHASE PHARMACEUTICALS INCS Sale	Chief ScientificOfficer	SSale	−7,155 sh	$5.86	−$41.9K	0
2017-01-31	TETRAPHASE PHARMACEUTICALS INCRestricted Stock UnitA Award	Chief ScientificOfficer	AAward	+30K sh	—	—	30,000
2017-01-30	TETRAPHASE PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award	Chief ScientificOfficer	AAward	+140K sh	—	—	140,000
2014-08-05	IDENIX PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	EVP, Chief Scientific Officer	DDisposition to Issuer	−250K sh	—	—	0

Recent filings

Accepted (ET)
Jan 184
Dumas Jacques0001209191-19-004601
SEC(opens sec.gov)
Jan 104
Dumas Jacques0001209191-19-003290
SEC(opens sec.gov)
Apr 44
Dumas Jacques0001209191-18-023582
SEC(opens sec.gov)
Jan 314
Dumas Jacques0001209191-18-006210
SEC(opens sec.gov)
Jan 194
Dumas Jacques0001209191-18-004651
SEC(opens sec.gov)
Nov 24
Dumas Jacques0001209191-17-058940
SEC(opens sec.gov)
Aug 244
Dumas Jacques0001209191-17-050140
SEC(opens sec.gov)
Aug 214
Dumas Jacques0001209191-17-049702
SEC(opens sec.gov)
Feb 14
TETRAPHASE PHARMACEUTICALS INC0001209191-17-006848
SEC(opens sec.gov)
Aug 54
IDENIX PHARMACEUTICALS INC0001209191-14-050674
SEC(opens sec.gov)

Companies

Address

C/O IDENIX PHARMACEUTICALS, INC. 320 BENT STREET

CAMBRIDGE, MA, 02141